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differences (RD) on ACS subjects0 outcomes are unclear in the real
world practice.
METHODS Data were analyzed from the 2005-2008 National Health
Insurance Research Database (NHIRD) in Taiwan. ACS subjects un-
dergoing CAG or PCI with intent to revascularization during the same
admission were enrolled. The major adverse cardiac events (MACE)
were cardiovascular death, myocardial infarction (MI) and stroke.
Other exploratory endpoint is heart failure (HF). RD was deﬁned as
cardiovascular outcomes between two geographic locations.
RESULTS 2481 patients with ACS were enrolled and the mean age was
65.012.9 years old. We found RD including admission charge, length
of hospital stay, and the percentage of hyperlipidemia, beta-blockers
use, angiotensin-converting-enzyme inhibitors (ACEI) use, and CAG.
Cox regression analysis showed that RD was associated with MACE
(P¼0.012) and MI (P¼0.005), but not HF (P¼0.094), cardiovascular
death (P ¼0.551) or stroke (P ¼0.733). Kaplan–Meier curves showed
two locations had signiﬁcant difference among MACE and MI (both
log-rank test p < 0.012). In the multivariate analysis, RD was associ-
ated with MACE (P ¼0.006) and MI (P ¼0.002).CONCLUSION In the real-world practice, RD might be an outcome
predictor of MACE and MI in ACS subjects.
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Time of Onset of Acute Myocardial Infarction to First Balloon Dilatation and
T Wave Alternans
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1Binawaluya Cardiac Center, Indonesia
BACKGROUND T-wave alternans (TWA) is a heart rate dependent
repolarization measurement and correlates with arrhythmia
vulnerability in animal and human studies. TWA is one of estab-
lished marker and can predict individuals at high risk of devel-
oping a potentially lethal cardiac arrhythmia. We evaluate the
association of onset of myocardial infarction and increased of TWA
in patients with acute ST-segment elevation myocardial infarction
(STEMI).
METHODS All patients with acute STEMI who underwent primary
percutaneous coronary intervention (PPCI) at Bina Waluya Cardiac
Center in periods of January 2011 to October 2011 were enrolled.
Those were having previous myocardial infarction was excluded.
TWA was measured using Treadmill test after 1 to 2 weeks after
discharge.
RESULTS A total of consecutive 27 patients were included in the
study. There were 25 man and 2 women, with the mean age 58.8 
9.9years. The median onset of STEMI and ﬁrst medical contact was 5.2
hours (0.5 to 11 hours) and the mean door to balloon was 149.5  97.8
minutes (62 to 432 minutes). The time between onsets of myocardial
infarction to the ﬁrst balloon dilatation was so-called pre-revascular-
ization time. No complication occurred. The mean LV EF was 59 
13.2% and End Diastolic Diameter (EDD)was 499.5 mm, and the End
Systolic Diameter (ESD) was 329.7 mm. There was signiﬁcant corre-
lation between pre-revascularization time and the TWA (r¼0.51,
p<0.01). The longer the pre-revascularization time, the longer the
TWA.
CONCLUSION The longer the pre-revascularization times the more
probability of having higher results of TWA and may inﬂuence
occurring of ventricular arrhythmia.
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BACKGROUND We conducted a retrospective examination of very
long-term clinical outcomes after stenting using sirolimus (SES) and
paclitaxel (PES)-eluting stents for patients with STEMI presented
within 48hrs from the onset.
METHODS The present study was a non-randomized, retrospective,
and single center study, recruiting 872 ﬁrst STEMI patients after
successful either SES (n¼547)or PES placement during from November
2004 to April 2012.
RESULTS The incidence of severe cardiac events comprising of
cardiac death, nonfatal recurrent MI, and deﬁnite stent thrombosis
in the SES group (8.6%) during the follow-up duration of 2173786
(days) was not signiﬁcantly different from that in the PES group
(6.2%, 1821696 days). However, the incidence of very late deﬁnite
stent thrombosis (VLST) in the SES group (1.5%) was signiﬁcantly
greater than that in the PES group (0, p¼0.041). However, after
adjusting the 29 baselines by a propensity-score matched analysis
produced 231 patients in each arm, the incidence of severe cardiac
events including VLST (0.4%) in the SES group (5.6%) was not
signiﬁcantly different from that in the PES group (6.1%). Cox pro-
portional hazard model showed that patients with LMCA disease
(hazard ratio¼11.6, 95% CI: 1.98-68.1, p¼0.007) and ﬁnal TIMI-grade
ﬂow 2-3 (0.145, 95% CI: 0.025-0.83, p¼0.030) were the predictors of
severe cardiac events.
CONCLUSION Thus, very long-term clinical outcomes of the ﬁrst-
generation DESs (SES vs. PES) for ﬁrst STEMI patients were favorable
and statistically equivalent in Japan.
